Research summary ·
Management of plexiform neurofibromas in neurofibromatosis type 1: An Italian Delphi consensus.
Written based on 1 research study on PubMed, searched on 15 Nov 2026.
What was studied
This is a guideline from a panel of 17 experts in Italy. They are experts in NF1, or neurofibromatosis type 1. The panel members came from many different fields. It is about plexiform neurofibromas, a kind of tumor seen in NF1. The panel first read past studies and wrote draft points. They then voted on the points online, with no names shown. The points were changed in rounds until the group agreed.
What they found
The panel agreed on 49 final points. They stress finding these tumors early. They back a scan of the whole body, called whole-body MRI. This scan shows how much tumor is inside the body. The panel says scans should be done and written up the same way. Lumps that look odd should be found and checked in good time. How often people get checks should depend on their own risk. People should learn the signs that a tumor may be turning into cancer. The panel also agreed on when to send people to a surgeon. They set out what counts as a tumor symptom. They said when a tumor cannot be taken out. They also covered how to use surgery and targeted drugs together.
What it means for patients
The authors say this gives a clear, hands-on plan for care of these tumors. It is meant to add to the advice that already exists worldwide. The panel calls for a planned way of making care choices. Under this plan, experts from many fields would share in these choices. It aims to help in areas where proof is still thin.
Why it is not certain yet
The points come from expert agreement, not from a new trial. The authors say the proof is still limited in some areas. All 17 experts on the panel came from Italy. The abstract does not list all 49 points in full.
Source
Management of plexiform neurofibromas in neurofibromatosis type 1: An Italian Delphi consensus.
PubMed · PMID 42776276We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Neurofibromatosis type 1 publications